Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) issued an announcement. In order to improve the strategic development layout, obtain a competitive advantage in the market on the basis of segmented management, and promote business development, the company plans to invest abroad to establish a holding subsidiary, Shandong Buchang Shengshi Pharmaceutical Co., Ltd. The registered capital of the newly established company is 50 million yuan, and the company plans to invest 33.5 million yuan, with a shareholding ratio of 67%.

Zhitong Finance App News, Buchang Pharmaceutical (603858.SH) issued an announcement. In order to improve the strategic development layout, obtain a competitive advantage in the market on the basis of segmented management, and promote business development, the company plans to invest abroad to establish a holding subsidiary, Shandong Buchang Shengshi Pharmaceutical Co., Ltd. The registered capital of the newly established company is 50 million yuan, and the company plans to invest 33.5 million yuan, with a shareholding ratio of 67%.